Compare Vertiv Holdings Co (VRT) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertiv Holdings Co vs Zoetis Inc — how do they compare? Vertiv Holdings Co trades at $296.43 (market cap $108.49B), while Zoetis Inc trades at $72.95 (market cap $31.14B). The key difference: Vertiv Holdings Co is far larger — about 3.5× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| VRT | ZTS | |
|---|---|---|
Market Cap | $108.49B | $31.14B |
Sector | Technology | Health |
52-Week High | $376.23 | $156.76 |
52-Week Low | $121.82 | $71.91 |
Enterprise Value | $108.72B | $38.70B |
Dividend Yield | 0.09% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertiv (VRT) trades at $297.49, up 10.14% in the last 24 hours, reflecting strong momentum driven by AI infrastructure demand. The stock exhibits a bullish technical trend with key resistance near $293 and support at $270. Fundamentally, the company shows robust growth with revenue rising to $10.23B in 2025 and net income reaching $1.33B, supported by a high ROE of 43.94%. Recent earnings beats and a consensus analyst price target of $386.58 highlight positive sentiment, though elevated valuation ratios like a P/E of 63.76 warrant caution.
The outlook for VRT remains positive due to its strategic position in the AI data center market, with projected revenue growth to $11.5B in 2026. However, risks include high valuation multiples, ongoing legal investigations, and dependence on tech sector capital expenditure cycles. Investors should weigh the growth potential against these factors, with analyst consensus strongly favoring a buy rating.
Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.
The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
